{"id":"https://genegraph.clinicalgenome.org/r/eb28f8e0-aaa4-4c16-87c1-f209b97afd6cv1.0","type":"EvidenceStrengthAssertion","dc:description":"The KCNMA1 gene is associated with autosomal dominant clinical disorders referred to as Liang-Wang syndrome (OMIM 618729) and paroxysmal nonkinesigenic dyskinesia (PNKD) type 3 with our without epilepsy (OMIM 609446) in the literature.  Recent reviews evaluating the phenotype of previously reported patients indicate heterozygous variants in KCNMA1 are associated with a disorder that has a spectrum of clinical phenotypes (PMID 34224328, 31427379).  Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found no difference in molecular mechanism(s) or phenotypic variability. Therefore, all of the autosomal dominant disease entities have been lumped into one disease entity, autosomal dominant generalized epilepsy-paroxysmal dyskinesia syndrome.  Of note, this gene has also been implicated in autosomal recessive generalized epilepsy-paroxysmal dyskinesia syndrome, which has been assessed separately.\n\nKCNMA1 was first reported in relation to an autosomal dominant generalized epilepsy-paroxysmal dyskinesia syndrome in 2005 (PMID 15937479).  The gene encodes the pore-forming alpha subunit of the “Big K+” (BK) large conductance calcium and voltage-activated K+ channel.  The mechanism for disease is heterozygous missense variants that may have either gain-of-function or loss-of-function effect on the BK potassium channel activity measured by patch clamp recording or expression in Xenopus laevis oocytes (PMID 34224328, 31152168, 15937479).  \n\nAt least 11 unique missense variants have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data, segregation data, and experimental data.  Variants in this gene have been reported in at least sixteen probands in eight publications (PMIDs: 15937479,  31152168, 26195193, 29330545, 29356177, 32633875, 34499417, 32132200). Variants in this gene segregated with disease in sixteen affected individuals with epilepsy, paroxysmal nonkinesigenic dyskinesia, or both (n = 5) over three generations in a large family (PMID: 15937479).  Additionally, two recurrent de novo variants, p.(Gly375Arg) and p.(Asn1053Ser) (published as p.(Asn995Ser) using an alternative reference sequence) have been identified in multiple individuals with a similar phenotype (PMID: 31152168, 26195193, 29330545, 34499417).  The maximum score for genetic evidence (12 pts.) has been reached.  \n\nIn summary, KCNMA1 is definitively associated with autosomal dominant generalized epilepsy-paroxysmal dyskinesia syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time.\n\nThis classification was approved by the ClinGen Epilepsy Gene Curation Expert Panel Working Group on March 1, 2022\n(SOP Version 8).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/eb28f8e0-aaa4-4c16-87c1-f209b97afd6c","GCISnapshot":"https://genegraph.clinicalgenome.org/r/4bd10bb7-67d0-4c30-a944-9a46fd2f361a","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/4bd10bb7-67d0-4c30-a944-9a46fd2f361a_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10005","date":"2022-03-08T10:47:57.115Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/4bd10bb7-67d0-4c30-a944-9a46fd2f361a_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10005","date":"2022-03-08T10:44:05.484Z","role":"Approver"}],"curationReasonDescription":"The association between KCNMA1 and autosomal dominant generalized epilepsy-paroxysmal dyskinesia syndrome has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. ","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4bd10bb7-67d0-4c30-a944-9a46fd2f361a_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1da7f08c-c971-4a25-afea-dbdb74999cdc","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1da7f08c-c971-4a25-afea-dbdb74999cdc_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Patch-clamp recordings showed that BK channels fail to elicit any potassium current under voltage stimulus ranging from −160 mV–160 mV, suggesting a LoF effect of this variant","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/1da7f08c-c971-4a25-afea-dbdb74999cdc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31152168","allele":{"id":"https://genegraph.clinicalgenome.org/r/9707169f-e6a3-49bc-9c73-6bba899e5c1f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001161352.2(KCNMA1):c.1066G>A (p.Gly356Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA377409131"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/bee9b25d-ffaf-4d27-8ce0-f396b5111572","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bee9b25d-ffaf-4d27-8ce0-f396b5111572_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Patch clamp recording indicates N536H enhances BK channel activation by promoting voltage dependent activation without affecting its Ca2+ dependent activation, suggeting a gain-of-function effect","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/bee9b25d-ffaf-4d27-8ce0-f396b5111572_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32633875","allele":{"id":"https://genegraph.clinicalgenome.org/r/622d5267-bfe7-49ac-a1f5-ea044602a7d3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001161352.2(KCNMA1):c.1606A>C (p.Asn536His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA377404997"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/a5465ac6-539e-4007-90c4-52e889889428","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a5465ac6-539e-4007-90c4-52e889889428_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34499417","allele":{"id":"https://genegraph.clinicalgenome.org/r/4aec10bf-7971-443c-bd7c-3eaa7b822832","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001161352.2(KCNMA1):c.1123G>A (p.Gly375Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA377409002"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/eb180df2-48ad-47a7-8e40-37a49a0606ab","type":"EvidenceLine","dc:description":"Assumed de novo, no confirmation of maternity and paternity","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/eb180df2-48ad-47a7-8e40-37a49a0606ab_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Expressed G354S and WT channels in Xenopus oocytes and the variant dramatically reduced single-channel conductance and ion selectivity","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/eb180df2-48ad-47a7-8e40-37a49a0606ab_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32132200","allele":{"id":"https://genegraph.clinicalgenome.org/r/975c505d-4a21-4d9d-b02d-32671d61efdd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001161352.2(KCNMA1):c.1060G>A (p.Gly354Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/561037"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/50007362-c8a3-472f-92b8-16daf9c37ea7","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/50007362-c8a3-472f-92b8-16daf9c37ea7_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Patch clamp recording indicates the variant markedly increased the macroscopic potassium current by increasing both the channel open probability and channel open dwell time consistent with gain-of-function effect","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/50007362-c8a3-472f-92b8-16daf9c37ea7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29330545","allele":{"id":"https://genegraph.clinicalgenome.org/r/dd69ef7a-b4a1-474d-b7e6-a03073e92cc0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001161352.2(KCNMA1):c.3158A>G (p.Asn1053Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10588480"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/b205649e-e9f3-46ef-b1bc-7dd88d679249","type":"EvidenceLine","dc:description":"Variant assumed de novo; maternity and paternity not confirmed","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b205649e-e9f3-46ef-b1bc-7dd88d679249_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26195193","allele":{"id":"https://genegraph.clinicalgenome.org/r/dd69ef7a-b4a1-474d-b7e6-a03073e92cc0"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/9dedd0d3-cf29-465c-ae6f-130f5c9ae907","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9dedd0d3-cf29-465c-ae6f-130f5c9ae907_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Patch-clamp recordings showed p.(Pro805Leu) markedly reduces the amplitude of the BK current (Fig. 5D) and  shifts the G-V curve to the positive voltage direction.  Western blot indicates it significantly reduced the expression level of the BK channel (Fig. 5E). Thus, the p.(Pro805Leu) variant is also a LoF variant.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/9dedd0d3-cf29-465c-ae6f-130f5c9ae907_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31152168","allele":{"id":"https://genegraph.clinicalgenome.org/r/dc323370-8682-443d-922d-49483c8c3d39","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001161352.2(KCNMA1):c.2588C>T (p.Pro863Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/975413"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/b0963874-6da0-4ed6-b6c7-bf560a29326c","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b0963874-6da0-4ed6-b6c7-bf560a29326c_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Patch-clamping experiments revealed that the p.(Gly375Arg) variant abolishes the function of the BK channel and blocks generation of potassium current (Fig. 1D), suggesting a LoF effect of this variant.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/b0963874-6da0-4ed6-b6c7-bf560a29326c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31152168","allele":{"id":"https://genegraph.clinicalgenome.org/r/4aec10bf-7971-443c-bd7c-3eaa7b822832"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/1636b0fa-7f89-4f10-95fa-dfd128744391","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1636b0fa-7f89-4f10-95fa-dfd128744391_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Patch clamp recording indicates the variant markedly increased the macroscopic potassium current by increasing both the channel open probability and channel open dwell time consistent with gain-of-function effect","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/1636b0fa-7f89-4f10-95fa-dfd128744391_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29330545","allele":{"id":"https://genegraph.clinicalgenome.org/r/dd69ef7a-b4a1-474d-b7e6-a03073e92cc0"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/a199e993-b10a-4399-b76f-755e535007a5","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a199e993-b10a-4399-b76f-755e535007a5_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":" Patch-clamp recordings showed that the p.(Asp984Asn) variant markedly reduces the activation of the BK channel by decreasing the mean macroscopic current amplitude of BK potassium current, suggesting it is a LoF variant","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/a199e993-b10a-4399-b76f-755e535007a5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31152168","allele":{"id":"https://genegraph.clinicalgenome.org/r/dd69ef7a-b4a1-474d-b7e6-a03073e92cc0"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/667da599-9297-4ae9-89fb-d5ee5cb8898a","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/667da599-9297-4ae9-89fb-d5ee5cb8898a_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Patch-clamp recordings showed that p.(Ile663Val) mutant BK channels failed to elicit any potassium current under the voltage stimulus from −160 mV–160 mV (Fig. 4D) suggesting a LoF effect of this variant. Western blot analyses revealed that the p.(Ile66Val) mutated BK channel moved much slower than the WT or other mutant channels through the gel","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/667da599-9297-4ae9-89fb-d5ee5cb8898a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31152168","allele":{"id":"https://genegraph.clinicalgenome.org/r/9652448e-2bba-47ba-8b92-7addb7732fff","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001161352.2(KCNMA1):c.1987A>G (p.Ile663Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/916048"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/2530198e-a86f-42ee-9afe-570a7c0be8e1","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2530198e-a86f-42ee-9afe-570a7c0be8e1_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Patch-clamp recordings showed that BK channels fail to elicit any potassium current under voltage stimulus ranging from −160 mV–160 mV, suggesting a LoF effect of this variant","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/2530198e-a86f-42ee-9afe-570a7c0be8e1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31152168","allele":{"id":"https://genegraph.clinicalgenome.org/r/b3fd142a-72ba-46cd-a520-bb11410b8082","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001161352.2(KCNMA1):c.1052C>A (p.Ser351Tyr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA377409158"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/c6e85146-b29a-49ac-b818-89f6827aa06e","type":"EvidenceLine","dc:description":"Variant assumed de novo with no confirmation of maternity or paternity","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c6e85146-b29a-49ac-b818-89f6827aa06e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26195193","allele":{"id":"https://genegraph.clinicalgenome.org/r/e21af0d9-9f5d-4abf-957b-1c287300a738","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001161352.2(KCNMA1):c.2824G>A (p.Glu942Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA377405404"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/f327f8c5-4423-48f2-9c56-66fa045491f9","type":"EvidenceLine","dc:description":"Downgrade due to assumed de novo variant without confirmation of maternity and paternity","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f327f8c5-4423-48f2-9c56-66fa045491f9_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Patch-clamping experiments revealed that the p.(Gly375Arg) variant abolishes the function of the BK channel and blocks generation of potassium current (Fig. 1D), suggesting a LoF effect of this variant.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/f327f8c5-4423-48f2-9c56-66fa045491f9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31152168","allele":{"id":"https://genegraph.clinicalgenome.org/r/4aec10bf-7971-443c-bd7c-3eaa7b822832"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/bfc26da7-4321-4f49-b27e-11a50a8ba90e","type":"EvidenceLine","dc:description":"assumed de novo; no confirmation of maternity or paternity","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bfc26da7-4321-4f49-b27e-11a50a8ba90e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29356177","allele":{"id":"https://genegraph.clinicalgenome.org/r/4c02bed4-1d56-4b44-b608-a50b664212b5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001161352.2(KCNMA1):c.1534A>G (p.Ile512Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/1001141"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/4bd10bb7-67d0-4c30-a944-9a46fd2f361a_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/41f7d35c-03bd-4285-89fc-a20aa7a09562_proband_segregation","type":"FamilyCosegregation","dc:description":"Large family with segregation of variant over multiple generations","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15937479","rdfs:label":"Family QW1","estimatedLodScore":3.31,"family":{"id":"https://genegraph.clinicalgenome.org/r/41f7d35c-03bd-4285-89fc-a20aa7a09562","type":"Family","rdfs:label":"Family QW1","member":{"id":"https://genegraph.clinicalgenome.org/r/1d5df5b6-c4a9-43a9-907d-ce36e8b45542","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15937479","rdfs:label":"Proband IV-8","allele":{"id":"https://genegraph.clinicalgenome.org/r/07d65c7d-c649-4559-a45c-c1977e0b0a04","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001161352.2(KCNMA1):c.1301A>G (p.Asp434Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA120421"}},"detectionMethod":"Genome-wide linkage scan with 382 microsatellite markers.  Lod scores of 3.68 and 3.73 at two markers on 10q22 that included 40 genes.  Suspected ion channel disorder due to epilepsy/movement disorder phenotype so performed candidate gene Sanger sequencing of VDAC2, encoding voltage-dependent anion channel 2, which showed no variants and KCNMA1 variant HET in proband. ","firstTestingMethod":"Linkage analysis","phenotypes":["obo:HP_0011147","obo:HP_0007166"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/fafa4c2f-c833-495f-a67b-807a5bd2deb1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15937479","allele":{"id":"https://genegraph.clinicalgenome.org/r/07d65c7d-c649-4559-a45c-c1977e0b0a04"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":13,"phenotypes":["obo:HP_0007166","obo:HP_0011147","obo:HP_0002069"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/1d5df5b6-c4a9-43a9-907d-ce36e8b45542"},"publishedLodScore":3.68,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/fafa4c2f-c833-495f-a67b-807a5bd2deb1","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fafa4c2f-c833-495f-a67b-807a5bd2deb1_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Expressed wild-type and D434G mutant BK channels in both Xenopus laevis oocytes and mammalian Chinese hamster ovary (CHO) cells and recorded current-voltage relations.  Mutant channels showed increased voltage and calcium-dependent activation. Corresponding to the shifts in voltage dependence of activation, the D434G currents activated faster than the wild-type currents in response to a depolarizing voltage pulse. ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/fafa4c2f-c833-495f-a67b-807a5bd2deb1_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/4bd10bb7-67d0-4c30-a944-9a46fd2f361a_experimental_evidence_line","type":"EvidenceLine","specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":0}],"evidenceStrength":"Definitive","sequence":4045,"specifiedBy":"GeneValidityCriteria8","strengthScore":12,"subject":{"id":"https://genegraph.clinicalgenome.org/r/qqk_JU4OS4s","type":"GeneValidityProposition","disease":"obo:MONDO_0012276","gene":"hgnc:6284","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_4bd10bb7-67d0-4c30-a944-9a46fd2f361a-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}